Advancing microbiome therapeutics: Vedanta Biosciences raises US$45.5m in funding
The company has generated a pipeline of microbial treatment programs for infectious diseases, autoimmune diseases, allergies and cancer
Industry news
Multimedia
Suppliers
Industry news
Multimedia
Suppliers
The company has generated a pipeline of microbial treatment programs for infectious diseases, autoimmune diseases, allergies and cancer